At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Noninvasive Breath Test in Order to Identify Patients at Risk for Developing Gestational Diabetesother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study Evaluating the Use of a Novel Noninvasive Breath Test to Identify Patients at Risk for Developing Gestational Diabetes
In Brief
An observational study evaluating Noninvasive Breath Test in Order to Identify Patients at Risk for Developing Gestational Diabetes for Gestational Diabetes. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The aim of our study is to evaluate the feasibility, and diagnostic value of oral 13C labelled glucose breath test compared to the GCT and OGTT tests.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGestational Diabetes
CountriesIsrael
CollaboratorsUniversity of Galway
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartDec 2020
Primary CompletionJun 2024
First PostedJan 2026
TodayJul 2026
First PostedJan 16, 2026
Enrollment StartDec 18, 2020
Primary CompletionJun 20, 2024
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 6 months ago
Interventions
Noninvasive Breath Test in Order to Identify Patients at Risk for Developing Gestational Diabetesother
After a short explanation on how to use the kit participants will be asked to sample their breath every 15 minutes starting 30 minutes before the ingestion of glucose and ending six hours after the ingestion.